Uncategorized
Featured Stories
DaVita Names New Leaders to Accelerate Care Transformation
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Announces Closing of Note Tender Offer
DaVita Inc. today announced that it has completed its tender offer for all of its outstanding 91/4% Senior Subordinated Notes due 2011. The note tender offer was originally announced on March 21,…
-
DaVita Revises Purchase Price in Tender Offer and Consent Solicitation for Its 9.25% Senior Subordinated Notes Due 2011
DaVita Inc. today revised the previously announced consideration to be paid in its cash tender offer for all of its outstanding 9.25% Senior Subordinated Notes due 2011. The tender offer is…
-
DaVita Revises Tender Offers and Announces Satisfaction of Financing Condition
DaVita Inc. today announced that in connection with its previously announced offer to purchase up to 24,000,000 of its common shares, it has increased the price at which it will purchase the…
-
DaVita Sets Purchase Price in Tender Offer and Consent Solicitation For Its 9.25% Senior Subordinated Notes Due 2011
DaVita Inc. today announced the consideration to be paid in its cash tender offer for all of its outstanding 9.25% Senior Subordinated Notes due 2011. The tender offer is subject to the terms and…
-
DaVita Announces Receipt of Requisite Consents for its 9.25% Senior Subordinated Notes Due 2011
DaVita Inc. today announced that, as of 5:00 PM, Eastern Standard Time, April 4, 2002 (the expiration date of the consent solicitation period), it had received the requisite consents from the…